Similarly, employing the same methodology to validate the prognostic implications of TETs overexpression, we noted that HCC patients with elevated levels of TET1 and TET3 had markedly shorter survival times than those with lower levels (Fig. 5b). Here, TET3 is linked to hepatocellular carcinoma.